These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Individual reactivity to Imuran, antithymocytic globulin and levamisol]. Korcáková L, Rovenský J, Pekárek J, Holub M, Kocandrle V. Cas Lek Cesk; 1982 Sep 30; 121(38-39):1180-3. PubMed ID: 6982754 [No Abstract] [Full Text] [Related]
5. [Levamisole effects on collagen disease lymphocytes in vitro and in vivo (author's transl)]. Hoshina H. Nihon Naika Gakkai Zasshi; 1979 Jun 30; 68(6):620-30. PubMed ID: 479657 [No Abstract] [Full Text] [Related]
6. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease. Levo Y, Rotter V, Ramot B. Biomedicine; 1975 Jun 30; 23(6):198-200. PubMed ID: 1082352 [Abstract] [Full Text] [Related]
7. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)]. Sakharchuk II, Skakal'skaia LM. Vrach Delo; 1982 Aug 30; (8):4-8. PubMed ID: 6983185 [No Abstract] [Full Text] [Related]
8. Reactivating effect of levamisole on cell-mediated immunity in gastrointestinal cancer patients. Miwa H, Orita K. Acta Med Okayama; 1977 Oct 30; 31(5):325-9. PubMed ID: 146404 [Abstract] [Full Text] [Related]
10. [Akne conglobata with immunodeficiency and its Levamisol treatment (author's transl)]. Westphal HJ, Schütt C, Kaben U, Mattheus A. Dermatol Monatsschr; 1981 Jul 30; 167(7):410-7. PubMed ID: 6456159 [No Abstract] [Full Text] [Related]
11. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)]. Lang JM, Bigel P, Giron C, Faradji A, Oberling F, Mayer S. Nouv Presse Med; 1979 Nov 12; 8(44):3629-32. PubMed ID: 316521 [Abstract] [Full Text] [Related]
12. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects. Luyckx M, Cazin M, Brunet C, Cazin JC, Devulder B, Gosselin P, Adenis L, Cappelaere P, Granier AM, Demaille A. Methods Find Exp Clin Pharmacol; 1983 Sep 12; 5(7):467-9. PubMed ID: 6608036 [Abstract] [Full Text] [Related]
13. [Immunomodulating effect of levamisole on cell-mediated immunity (author's transl)]. Miwa H, Orita K. Nihon Gan Chiryo Gakkai Shi; 1981 Oct 20; 16(6):1231-8. PubMed ID: 7037998 [No Abstract] [Full Text] [Related]
14. The treatment of sarcoidosis by levamisole. Cole PJ, Citron KM, Plowman PN, Evans TG, Vick RM. Br J Dis Chest; 1979 Oct 20; 73(4):367-72. PubMed ID: 554668 [Abstract] [Full Text] [Related]
15. Levamisole and cellular immunity in rheumatoid arthritis--clinical and laboratory correlates. Levy J. J Rheumatol Suppl; 1978 Oct 20; 4():63-70. PubMed ID: 366145 [Abstract] [Full Text] [Related]
16. [Cell mediated immunity in sarcoidosis patients]. Haskovcová H, Hausner P, Altmann V, Votava V. Allerg Immunol (Leipz); 1976 Oct 20; 22(2):123-6. PubMed ID: 136877 [Abstract] [Full Text] [Related]
17. Levamisole and cellular immunity in rheumatoid arthritis--a review. Mowat AG. J Rheumatol Suppl; 1978 Oct 20; 4():55-61. PubMed ID: 366144 [Abstract] [Full Text] [Related]
19. [The evidence capacity of the lymphocyte-transformation-test and the quantitative immunoglobulin-determination in sarcoidosis (author's transl)]. Zochert J, Thomas U, Bösel B. Z Erkr Atmungsorgane; 1977 Aug 30; 149(2):243-6. PubMed ID: 416607 [Abstract] [Full Text] [Related]
20. In vitro reversal of cellular unresponsiveness induced by levamisole. Golding H, Golding B, Jacobson R, Lomnitzer R, Koornhof HJ, Rabson AR. Clin Exp Immunol; 1976 Nov 30; 26(2):295-301. PubMed ID: 791550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]